Early appointment of biological therapy of psoriasis
Abstract
The article is of a review nature and contains up-to-date information on the use of genetically engineered drugs in patients with psoriasis, psoriatic arthritis in the projection of the concept of early prescription of biological therapy. The data on the feasibility of early use of genetically engineered drugs to improve the prognosis of the disease and improve the quality of life.
About the Authors
L. S. Kruglova
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
A. A. Hotko
Clinical Dermatovenerologic Dispensary
Russian Federation
Russian Federation
M. A. Petriy
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Review
For citations:
Kruglova L.S., Hotko A.A., Petriy M.A. Early appointment of biological therapy of psoriasis. Medical alphabet. 2019;1(7):25-28. (In Russ.)
Views:
494
Email this article 